1. Home
  2. PACB vs ARDC Comparison

PACB vs ARDC Comparison

Compare PACB & ARDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • ARDC
  • Stock Information
  • Founded
  • PACB 2000
  • ARDC 2012
  • Country
  • PACB United States
  • ARDC United States
  • Employees
  • PACB N/A
  • ARDC N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • ARDC Investment Managers
  • Sector
  • PACB Industrials
  • ARDC Finance
  • Exchange
  • PACB Nasdaq
  • ARDC Nasdaq
  • Market Cap
  • PACB 364.2M
  • ARDC 330.8M
  • IPO Year
  • PACB 2010
  • ARDC N/A
  • Fundamental
  • Price
  • PACB $1.27
  • ARDC $14.07
  • Analyst Decision
  • PACB Buy
  • ARDC
  • Analyst Count
  • PACB 13
  • ARDC 0
  • Target Price
  • PACB $2.46
  • ARDC N/A
  • AVG Volume (30 Days)
  • PACB 8.5M
  • ARDC 115.8K
  • Earning Date
  • PACB 05-08-2025
  • ARDC 01-01-0001
  • Dividend Yield
  • PACB N/A
  • ARDC 9.84%
  • EPS Growth
  • PACB N/A
  • ARDC N/A
  • EPS
  • PACB N/A
  • ARDC N/A
  • Revenue
  • PACB $154,014,000.00
  • ARDC N/A
  • Revenue This Year
  • PACB $7.15
  • ARDC N/A
  • Revenue Next Year
  • PACB $26.20
  • ARDC N/A
  • P/E Ratio
  • PACB N/A
  • ARDC N/A
  • Revenue Growth
  • PACB N/A
  • ARDC N/A
  • 52 Week Low
  • PACB $1.08
  • ARDC $11.56
  • 52 Week High
  • PACB $3.70
  • ARDC $14.30
  • Technical
  • Relative Strength Index (RSI)
  • PACB 46.94
  • ARDC 33.42
  • Support Level
  • PACB $1.08
  • ARDC $14.02
  • Resistance Level
  • PACB $1.36
  • ARDC $14.25
  • Average True Range (ATR)
  • PACB 0.09
  • ARDC 0.10
  • MACD
  • PACB 0.01
  • ARDC 0.03
  • Stochastic Oscillator
  • PACB 65.52
  • ARDC 24.19

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About ARDC Ares Dynamic Credit Allocation Fund Inc.

Ares Dynamic Credit Allocation Fund Inc is a closed-ended, diversified management investment company. The fund's investment objective is to provide an attractive level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of senior secured loans (Senior Loans) made to companies whose debt is rated below investment grade; corporate bonds (Corporate Bonds) that are high yield issues rated below investment grade; other fixed-income instruments of a similar nature that may be represented by derivatives; and securities of collateralized loan obligations (CLOs).

Share on Social Networks: